Terug
39
Dagbereik
€ 2,68
€ 2,77
52-Weeksbereik
€ 2,68
€ 4,50
Volume
7.000
50D / 200D Gem.
€ 2,77
/
€ 3,32
Vorige Slotkoers
€ 2,77
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 46,6 | 0,4 |
| P/B | 2,1 | 2,9 |
| ROE % | 4,5 | 3,7 |
| Net Margin % | 7,4 | 3,9 |
| Rev Growth 5Y % | 25,1 | 10,0 |
| D/E | 0,3 | 0,2 |
Koersdoel Analisten
Hold
€ 42,00
+1416.2%
Forward K/W
25,6
Forward WPA
€ 0,11
WPA Groei (sch.)
+0,0%
Omzet Sch.
460 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 0,15
€ 0,15 – € 0,15
|
550 M | 1 |
| FY2027 |
€ 0,13
€ 0,13 – € 0,13
|
500 M | 1 |
| FY2026 |
€ 0,11
€ 0,11 – € 0,11
|
460 M | 1 |
Belangrijkste Punten
Revenue grew 25,13% annually over 5 years — strong growth
Earnings grew 69,19% over the past year
ROE of 4,48% is below average
Debt/Equity of 0,34 — conservative balance sheet
Generating 90,60M in free cash flow
P/E of 46,55 — premium valuation
Groei
Revenue Growth (5Y)
25,13%
Revenue (1Y)13,39%
Earnings (1Y)69,19%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
4,48%
ROIC5,96%
Net Margin7,36%
Op. Margin17,53%
Veiligheid
Debt / Equity
0,34
Current Ratio1,95
Interest Coverage3,53
Waardering
P/E Ratio
46,55
P/B Ratio2,08
EV/EBITDA22,02
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13,39% | Revenue Growth (3Y) | 13,19% |
| Earnings Growth (1Y) | 69,19% | Earnings Growth (3Y) | 78,35% |
| Revenue Growth (5Y) | 25,13% | Earnings Growth (5Y) | 47,65% |
| Profitability | |||
| Revenue (TTM) | 425,00M | Net Income (TTM) | 31,30M |
| ROE | 4,48% | ROA | 2,82% |
| Gross Margin | 68,89% | Operating Margin | 17,53% |
| Net Margin | 7,36% | Free Cash Flow (TTM) | 90,60M |
| ROIC | 5,96% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,34 | Current Ratio | 1,95 |
| Interest Coverage | 3,53 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 46,55 | P/B Ratio | 2,08 |
| P/S Ratio | 3,43 | PEG Ratio | 0,55 |
| EV/EBITDA | 22,02 | Dividend Yield | 0,00% |
| Market Cap | 1,46B | Enterprise Value | 1,64B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 425,00M | 374,80M | 331,73M | 281,31M | 173,35M |
| Net Income | 31,30M | 18,50M | 9,84M | -7,20M | 6,59M |
| EPS (Diluted) | 0,06 | 0,04 | 0,02 | -0,02 | 0,02 |
| Gross Profit | 292,80M | 258,30M | 229,43M | 193,99M | 122,85M |
| Operating Income | 74,51M | 49,20M | 41,27M | 39,36M | 21,60M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,11B | 1,11B | 973,68M | 923,56M | 640,72M |
| Total Liabilities | 401,00M | 403,30M | 446,97M | 442,06M | 282,08M |
| Shareholders' Equity | 698,90M | 699,90M | 526,37M | 481,81M | 357,41M |
| Total Debt | 238,70M | 233,60M | 313,80M | 220,96M | 180,37M |
| Cash & Equivalents | 55,00M | 64,80M | 37,50M | 42,19M | 55,11M |
| Current Assets | 213,50M | 222,70M | 158,94M | 206,69M | 131,47M |
| Current Liabilities | 109,40M | 109,90M | 74,89M | 166,26M | 72,69M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#630 of 1024
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026